Showing 34,982 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Reproductive health

Menstrual health and HIV

About HIV
August 2025
Sleep

Sleep and HIV

About HIV
August 2025
Alcohol

Alcohol and HIV

About HIV
August 2025
Finance & funding

NIH ponders overhauling HIV budget to capitalize on prevention breakthrough

Editor's pick
Science Magazine
12 August 2025
The search for an HIV prevention vaccine

WHO Decries US Cancellation of mRNA Vaccine Research as “Unfortunate and Untimely”

Editor's pick
Health Policy Watch
9 August 2025
Government, leadership & policy

A proposed California bill aims to protect coverage for HIV prevention despite federal threats

Editor's pick
Los Angeles Times
9 August 2025
Treatment guidelines

IAS 2025: Major updates to WHO guidelines: PrEP, injectable ART, infant feeding and prophylaxis and complications including mpox

Editor's pick
i-Base
9 August 2025
Finance & funding

‘Impossible to rebuild’: NIH scientists say Trump cuts will imperil life-saving research

Editor's pick
The Guardian
9 August 2025
Adherence

Urine Tenofovir Rapid Assay Improves ART Adherence, Not HIV Viral Suppression

Editor's pick
Infectious Disease Advisor
9 August 2025
Activism & civil society

'All sides' to blame in Prince Harry charity row, watchdog finds

Editor's pick
BBC News
9 August 2025
Cardiovascular disease

Statins and HIV: What Clinicians Need to Know

Editor's pick
TheBodyPro
9 August 2025
Low CD4 count

Limited access to CD4 tests misses late diagnoses and advanced HIV disease (AHD)

Editor's pick
i-Base
9 August 2025
The search for a cure

The First Widespread Cure for HIV Could Be in Children

Editor's pick
Wired (requires free registration)
5 August 2025
HIV treatment

US FDA Approves New Biktarvy Indication For People With HIV Who Are Treatment Experienced And Restarting Antiretroviral Treatment

Editor's pick
Gilead Sciences press release
4 August 2025
Drug-resistant TB

Extensively Drug-Resistant TB Outcomes Remain Poor in Europe

Editor's pick
Medscape (requires free registration)
4 August 2025
Pregnancy and vertical transmission

Some U.S. newborns still get HIV despite efforts to screen for it. Here’s why

Editor's pick
Science News
4 August 2025
PrEP policies & guidelines

Gilead’s Regulatory Delays Block Access to Lenacapavir for PrEP

Editor's pick
Health GAP (Global Access Project)
4 August 2025
Cancer

HIV remains an exclusion in 75% of pivotal cancer studies

Editor's pick
i-Base
4 August 2025
Treatment simplification strategies

Switching to dual ART after durable suppression in West and Central Africa

Editor's pick
i-Base
4 August 2025
Mpox (monkeypox)

WHO Urges Rapid Treatment for Concurrent HIV and Mpox

Editor's pick
Medscape (requires free registration)
4 August 2025
PrEP policies & guidelines

With RFK Jr. reportedly weighing preventive services panel revamp, HIV PrEP drugmakers could be at risk: analysts

Editor's pick
FiercePharma
4 August 2025
Organ transplants

Similar survival rates found in people who get dual organ transplants-regardless of HIV status

Editor's pick
CATIE
4 August 2025
Weight gain & lipodystrophy

Weight Gain Linked to Lower Quality of Life in HIV

Editor's pick
American Journal of Managed Care
4 August 2025
New & experimental HIV treatments

Ulonivirine Shows Promise for Weekly Oral HIV Treatment

Editor's pick
POZ
4 August 2025